BACKGROUND
Invasive Escherichia coli disease (IED) caused by extraintestinal pathogenic Escherichia coli (ExPEC) can lead to bacteraemia and sepsis. ExPEC9V is a conjugate vaccine targeting nine E coli O-serotypes that account for most E coli bloodstream infections. We aimed to evaluate ExPEC9V for safety, immunogenici...
M. Bonten, C. Butler, Andrew Edwards et al.· Lancet. Infectious Diseases...· 1 citation
Promising multicomponent influenza-COVID-19 vaccine candidates currently being evaluated in clinical trials may represent an important advancement in adult immunization strategy, and a meaningful opportunity to strengthen protection against two of the most consequential respiratory pathogens worldwide.
W. Schaffner, S. Gravenstein, S. Kissler et al.· Vaccine· 0 citations
Both mRNA-1273 and BNT162b2 mRNA vaccines elicit similarly robust humoral immunity in NHRs, supporting their interchangeable use in booster strategies, and underscore the importance of timely booster administration over exact product selection in protecting this high-risk, immunosenescent population.
Olajide J. Olagunju, Oladayo A. Oyebanji, Debbie Keresztesy et al.· Human Vaccines & Immunothera...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.